NCT03059238View on ClinicalTrials.gov

Parecoxib Versus Celecoxib Versus Oxycodone in Pain Control for Transcatheter Chemoembolization Procedure

PHASE3CompletedINTERVENTIONAL

Enrollment

213

Participants

Timeline

Start Date

September 30, 2016

Primary Completion Date

March 31, 2019

Study Completion Date

March 31, 2019

Conditions

Liver CancerPain Postoperative

Interventions

DRUG

Celecoxib 200mg oral capsule

DRUG

parecoxib sodium

DRUG

controlled-release oxycodone

Trial Locations (1)

500060

Minimally Invasive Interventional Division, Department of Medical Imaging and Interventional Radiology, Sun Yat-sen University Cancer Center,, Guangzhou

All Listed Sponsors

lead

Sun Yat-sen University

OTHER

NCT03059238 - Parecoxib Versus Celecoxib Versus Oxycodone in Pain Control for Transcatheter Chemoembolization Procedure | Biotech Hunter | Biotech Hunter